Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Medical Societies Ask, What’s in a Name?

Kurt Ullman  |  Issue: May 2011  |  May 16, 2011

There are also historical concerns about the individual that can cause a push to change the name. In this case, some thought this was needed because of Dr. Wegener’s active participation in the medical establishment of the Nazi party during World War II.

Richard Panush, MD, professor of medicine in the Division of Rheumatology at the Keck School of Medicine, University of Southern California in Los Angeles, has an interest in the history of medicine and has contributed to the discussion of issues relevant to the crimes of Nazi physicians. “It is important that professional societies address the issue of moral, ethical, and professional characteristics of the person in cases such as this,” he says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

There is no evidence that Wegener was directly involved in war crimes during his tenure as director of the health authority in Lodz, Poland. He was involved in the Nazi medical establishment’s goal of preserving “racial hygiene.”

“While his connection to the Nazi regime was an early impetus for change, a critical evaluation of how we name diseases is the more important piece here,” says Dr. Matteson. “What we really want to do in medicine is to give diseases more scientifically appropriate names. Granulomatosis with polyangiitis references the two major features of the illness and is substantially more descriptive than the old name.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

ACR and Others Pushing for Change

The ACR cooperated with the European League Against Rheumatism (EULAR) and the American Society of Nephrology when the name change was suggested. A group of experts in the disease representing the associations met and reached a consensus on changing the name to granulomatosis with polyangiitis. They added Wegener’s as a parenthetical during a transition period.

“The changeover may take as long as five years to complete,” says Dr. Matteson. “In the interim we want make sure the disease is easily identifiable and searchable, so Dr. Wegener’s name will remain attached for a while.”

To get the word out about the change, the presidents of all three professional societies published articles in their journals.1 Letters outlining the suggested name change have been sent to the editors of most major journal editors and the National Library of Medicine.

Both Drs. Borenstein and Matteson agree that it will take some time to have the changes take full effect. Some of it will be people wanting to continue with what they learned in medical school, some just what a physician feels comfortable using.

Page: 1 2 3 | Single Page
Share: 

Filed under:Practice SupportQuality Assurance/Improvement Tagged with:A&RAC&RDiseaseWegener's Granulomatosis

Related Articles
    Prepare NOW for ICD-10 Medical Coding Transition

    Prepare NOW for ICD-10 Medical Coding Transition

    July 14, 2015

    The ICD-10 page on the Centers for Medicare & Medicaid Services (CMS) website features a countdown clock that shows the time left until Oct. 1, 2015, the date on which compliance with the new code set becomes mandatory. By the time this issue goes to press, the clock will read 90 or fewer days. Time…

    The Granulomatosis of Wegener’s

    May 16, 2011

    Delving deeper into the nonvasculitis aspects of the disease

    Rheum After 5: Dr. Eric Matteson Writes Rheumatic Disease History

    August 12, 2020

    Over the past 20 years, Eric L. Matteson, MD, MPH, emeritus chair, Division of Rheumatology, and emeritus professor of medicine at the Mayo Clinic College of Medicine and Science, Rochester, Minn., as well as a past president of the Rheumatology Research Foundation, has authored or co-authored six books about the history of rheumatic disease and…

    Plan Now for ICD-10 Changeover

    May 16, 2011

    Coding changes will have an impact on staff, physicians, and even the finances of rheumatology practices

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences